Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases

In Ethiopia, hepatitis B virus infections are prevalent and highly endemic. Additionally, there has been a significant increase in hospital admissions, morbidity, and mortality associated with hepatitis B viru… Continue reading on BioMed Central

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Background CD4+ T-cell lymphocytopenia and immune dysfunction are factors that drive the onset and persistence of Kaposi sarcoma (KS) in people with (PWH) and without HIV. Standard chemotherapy agents for KS can contribute to increasing CD4+ T cell lymphocytopenia. IL-7 is a cytokine that is essential in T-cell development, proliferation and homeostasis. In PWH, IL-7… Continue reading Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

An Extremely Successful Vaccine Story

by Gertrud U. Rey One of the most noteworthy advances in biomedical science is the vaccine for human papillomavirus (HPV). It has significantly changed the diagnostic and prognostic landscape in the field of cervical cancer. Cervical cancer is the fourth most common cancer in women globally, and it is a particular problem in low-income countries… Continue reading An Extremely Successful Vaccine Story

Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

Despite its range of disease associations, Epstein-Barr virus (EBV) treatments or vaccines are lacking. Joyce et al. determined EBV gp350 structures complexed with either its human receptor, CR2, or virus-neutralizing antibodies (nAbs), thus illustrating structural convergence of viral receptor and nAbs and offering insights for vaccines and therapeutics for EBV.